47.70
price up icon1.27%   0.6477
 
loading

Finanzdaten der Avidity Biosciences Inc-Aktie (RNA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
144.56%
3.847
1.573 2.336 2.045 3.543
Operating Expenses
31.48%
174.99
133.09 100.47 84.67 80.73
Benefits Costs and Expenses
100.00%
-
117.35 - - 72.40
Costs And Expenses
49.12%
174.99
117.35 100.47 84.67 72.40
Operating Income/Loss
30.13%
-171.14
-131.52 -98.13 -82.63 -77.19
Nonoperating Income/Loss
12.18%
13.83
15.74 17.74 11.83 8.332
Income/Loss From Continuing Operations Before Tax
103.32%
3.847
-115.77 2.336 -70.79 -68.86
Income/Loss From Continuing Operations After Tax
35.88%
-157.31
-115.77 -80.40 -70.79 -68.86
Net Income/Loss
35.88%
-157.31
-115.77 -80.40 -70.79 -68.86
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.30%
129.62
129.23 123.38 106.93 87.21
Diluted Average Shares
0.30%
129.62
129.23 123.38 106.93 87.21
Basic Earnings Per Share
34.44%
-1.21
-0.90 -0.65 -0.65 -0.79
Diluted Earnings Per Share
34.44%
-1.21
-0.90 -0.65 -0.65 -0.79
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$24.80
price up icon 1.08%
$84.83
price up icon 1.01%
$24.80
price down icon 7.89%
$103.16
price down icon 1.99%
$134.01
price up icon 1.38%
biotechnology ONC
$299.49
price down icon 3.04%
Kapitalisierung:     |  Volumen (24h):